The CDCN’s Annual “Accelerating Research & Treatment for Castleman Disease,” Working Dinner helps to disseminate cutting edge Castleman disease research
The Castleman Disease Collaborative Network (CDCN) will host the 11th Annual “Accelerating Research & Treatment for Castleman Disease,” working dinner in-person on Saturday, December 10, 2022 at the annual American Society of Hematology Meeting in New Orleans, Louisiana. The CDCN is delighted to have this event again in-person and we hope to see you in New Orleans!
The CDCN in-person working dinner will be attended by physicians and researchers from around the globe, who are dedicated to advancing the understanding and treatment of Castleman disease. The event serves as an opportunity for the CDCN’s network of physicians and researchers to discuss cutting edge research and important issues for patient care.
This event was co-sponsored by the CDCN and EUSA Pharma.
RSVP for the event here.
We will be showcasing research related to Castleman disease for 55 minutes (6:30-7:25PM CST) before the working dinner during an optional poster session. If you would like to present your research during this time, please submit an abstract here by Friday, November 11th.
Preliminary Schedule:
Saturday, December 10, 2022
| 6:30 – 7:25 PM CST | [Optional] “Drinks and Data” Poster Session |
| 7:30 – 7:35 PM CST | Welcome David Fajgenbaum, MD, MBA, MSc |
| 7:35 – 7:55 PM CST | Overview of CD and CDCN Award Presentation David Fajgenbaum, MD, MBA, MSc |
| 7:55 – 8:10 PM CST | Treatment of UCD and iMCD Frits van Rhee, MD, PhD, MRCP (UK), FRCPath |
| 8:10 – 8:25 PM CST | Discussion Group Session |
| 8:25 – 8:40 PM CST | Research update 1: CXCL13 is a predictive biomarker in iMCD Sheila Pierson, MS |
| 8:40 – 8:50 PM CST | Research update 2: Anti-CXCL13 treatment in a murin model of iMCD Kazuyuki Yoshizaki, MD, PhD |
| 8:50 – 8:55 PM CST | Q & A |
| 8:55 – 9:10 PM CST | Research update 3: Novel insights from Transcriptomics of CD lymph nodes Michael Gonzalez, PhD |
| 9:10 – 9:25 PM CST | Discussion Group Session |
| 9:25 – 9:30 PM CST | Closing Remarks David Fajgenbaum, MD, MBA, MSc |
| 9:30 PM CST | ADJOURN |
This annual meeting is a tremendous example of the power of the CDCN’s collaborative research approach to defeating Castleman disease
If you missed last year’s CDCN’s “Accelerating Research & Treatment for Castleman Disease,” Virtual Working Dinner you can view the recording of the presentations here.
The last in-person CDCN Annual “Accelerating Research & Treatment for Castleman Disease,” Working Dinner was held during the 2019 ASH Meeting in Orlando Florida from December 7th to December 10th at the Rosen Centre. Research related to Castleman disease was showcased in the first hour of the Working Dinner.